Navigation Links
Improving our ability to peek inside molecules
Date:9/16/2008

LIVERMORE -- It's not easy to see a single molecule inside a living cell.

Nevertheless, researchers at Lawrence Livermore National Laboratory are helping to develop a new technique that will enable them to create detailed high-resolution images, giving scientists an unprecedented look at the atomic structure of cellular molecules.

The LLNL team is collaborating with scientists across the country and in Germany and Sweden to utilize high-energy X-ray beams, combined with complex algorithms, to overcome difficulties in current technology.

The work began more than five years ago as a Laboratory Directed Research and Development (LDRD) project, headed by Stefano Marchesini. He has since transferred to Lawrence Berkeley Lab (LBNL), leaving the project in the hands of Stefan Hau-Riege, a materials science physicist at LLNL.

For now, the Advanced Light Source at LBNL and the FLASH facility in Hamburg, Germany, are being used to provide the X-ray beams. But a new facility under construction at Stanford University, the Linac Coherent Light Source (LCLS), will provide additional capabilities and greater imaging accuracy when it comes on line next year.

Another light source being built in Hamburg will be used as well. When completed in late 2013, the X-ray Free Electron Laser (XFEL) will be the world's longest artificial light source.

Using high-energy, extremely short-pulse - less than 100 femtoseconds, or one quadrillionth of a second - X-ray beams to examine nanoscale objects is not a new concept. The difficulty lies with the algorithms to convert the resulting patterns into usable images.

One method to increase the signal and resolution of the image is to include a second item with known features during the laser imaging. Known as a "reference object," it gives the researchers additional information with which to process the imaging data.

What is new is to use a very special reference object calle
'/>"/>

Contact: Bob Hirschfeld
newsbob@llnl.gov
925-422-2379
DOE/Lawrence Livermore National Laboratory
Source:Eurekalert

Page: 1 2

Related biology news :

1. Improving industry efficiency through environmental innovations
2. Biodegradable polymers show promise for improving treatment of acute inflammatory diseases
3. Improving swine waste fertilizer
4. Stroke study reveals key target for improving treatment and suggests that Gleevec may help
5. NOAA study shows eastern tropical pacific ocean dolphin populations improving
6. Improving care and knowledge in translational research to fight breast cancer
7. Improving detection of nuclear smuggling goal of computer model of mechanical engineer
8. UV light improving chances of fighting cancer
9. Improving science, technology in Africa is aim as G-8, African, UN experts convene in Berlin
10. Arctic science conference to focus on northern sustainability
11. The viability of hydrogen transportation markets: Chicken or egg?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013) - A novel vaccine study from ... research that will be unveiled at the American Association ... meeting takes place Monday, May 20 - Wednesday, May ... , "The main goal of a vaccine is ... pathogen that causes the disease", explained Dr. Hemachand Tummala, ...
(Date:5/19/2013)... at the University of California, Davis have engineered a ... for light. They report their findings today at ... Microbiology. , "In this work, we used synthetic biology ... carbon dioxide and light energy for growth) cyanobacterial metabolism ... Jordan McEwen, the lead researcher on the study. ...
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
Breaking Biology News(10 mins):Germ-fighting vaccine system makes great strides in delivery 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2
... with epilepsy carry might enable doctors to better predict ... suggest basic findings by researchers at the Duke University ... University College London. Patients often undergo a lengthy process ... anti-epilepsy drugs appropriate for them. , The researchers found ...
... anthropology expedition to Ethiopia's Lake Turkana basin, researchers have ... are roughly 195,000 years old. The researchers believe ... all trace to an ancient line that first evolved ... as 50,000 years ago. , Ian McDougall of Australian ...
... Professor Frank J. Slack at Yale University has identified a ... cancer, presenting new possibilities for diagnosis and treatment. The work ... Developmental Cell. , The oncogene Ras is out of control ... or activated by mutation. According to Slack, a member of ...
Cached Biology News:Gene variations explain drug dose required to control seizures 2Gene variations explain drug dose required to control seizures 3Gene variations explain drug dose required to control seizures 4New Clues Add 40,000 Years to Age of Human Species 2New Clues Add 40,000 Years to Age of Human Species 3New Clues Add 40,000 Years to Age of Human Species 4Yale Scientists Find MicroRNA Regulates Ras Cancer Gene 2
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...
(Date:5/21/2013)... As the R&D sector becomes increasingly ... industry to deliver better products, faster. Collaborations between ... often means turning big ideas into reality, within ... with Sensidose AB and Recipharm, is one example ... market sooner. The partnership resulted in the development ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
... 2010 Physicians at Thomas Jefferson University Hospital reported ... for fully automated interpretation of coronary CT angiography (cCTA) ... coronary artery disease (CAD) in the major coronary arteries ... in Chicago at the Radiological Society of North America ...
... between scientists in Donostia-San Sebastian and the University of Kiel ... determine and control the number of atoms in contact between ... same time as the electric current passing through the union ... Nanotechnology journal. One of the key problems in ...
... led by the European Science Foundation to identify the ... goes beyond space-related technologies to bring in expertise from ... and nanotechnology to energy, nuclear propulsion and robotics. ... and give scientists new tools. Yet currently space organisations ...
Cached Biology Technology:Rcadia COR Analyzer System Safely Rules Out Coronary Artery Disease in Main Coronary Arteries and Branch Vessels 2Bridging between Earth and space: technology breakthroughs for scientific progress 2
Prostaglandin E2 Luminex Standard Product Lines: Unspecified...
Rabbit polyclonal to HMGB1 (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 3146 SwissProtID: P09429...
Eppendorf tube holder, for Tube rack 175 x 12 mm, 100. Category: Chromatography Systems & Accessories, Systems....
ERalpha (Ser 104/106)...
Biology Products: